Abstract
Group B streptococcus (GBS) emerged in the 1960s as the leading cause of neonatal disease in the USA,1 and yet the reason for its emergence is unknown. Possible reasons are past underdiagnosis or a change in the population structure of GBS.2 Intrapartum antibiotic prophylaxis (IAP) was recommended as the prevention strategy for early-onset invasive GBS (EOGBS),3 and was adopted by various high-income countries. As a result, a substantial decline in the incidence of neonatal disease was observed.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
